Erick DeVinney - Feb 15, 2022 Form 4 Insider Report for Axogen, Inc. (AXGN)

Role
VP Peripheral Nerve Science
Signature
/s/Erick DeVinney
Stock symbol
AXGN
Transactions as of
Feb 15, 2022
Transactions value $
-$3,006
Form type
4
Date filed
2/17/2022, 03:05 PM
Previous filing
Dec 29, 2021
Next filing
Mar 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXGN Common Stock Award $0 +1.18K +1.35% $0.00 88.4K Feb 15, 2022 Direct F1, F2
transaction AXGN Common Stock Tax liability -$3.01K -357 -0.4% $8.42 88.1K Feb 15, 2022 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This reflects the number of shares that became vested as of February 15, 2022 upon the attainment of certain performance criteria.
F2 Includes 2 shares acquired under the Axogen stock purchase plan on December 31, 2021.
F3 The reported shares were sold, in compliance with company policy as to delivery of compensation based equity, with proceeds from such being used to cover the Reporting Person's tax withholding liability in connection with a portion of a performance stock award that vested on February 15, 2022.